85
Views
39
CrossRef citations to date
0
Altmetric
CASE REPORT

Reactivation of Toxoplasma Retinochoroiditis Under Atovaquone Therapy in an Immunocompetent Patient

, , , &
Pages 185-187 | Accepted 26 Feb 2006, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Laura Vanagas, Victoria Jeffers, Silvina S Bogado, Maria C Dalmasso, William J Sullivan$suffix/text()$suffix/text() & Sergio O Angel. (2012) Toxoplasma histone acetylation remodelers as novel drug targets. Expert Review of Anti-infective Therapy 10:10, pages 1189-1201.
Read now

Articles from other publishers (37)

Mike dos Santos, Andréia Luiza Oliveira Costa, Guilherme Henrique de Souza Vaz, Gabriela Carolina Alves de Souza, Ricardo Wagner de Almeida Vitor & Érica S. Martins-Duarte. (2023) Medicines for Malaria Venture Pandemic Box In Vitro Screening Identifies Compounds Highly Active against the Tachyzoite Stage of Toxoplasma gondii. Tropical Medicine and Infectious Disease 8:12, pages 510.
Crossref
Sharmin Sultana, Gilberto González-Parra & Abraham J. Arenas. (2023) Analysis of Within-Host Mathematical Models of Toxoplasmosis That Consider Time Delays. Mathematics 11:21, pages 4469.
Crossref
Jenni A. Hayward, F. Victor Makota, Daniela Cihalova, Rachel A. Leonard, Esther Rajendran, Soraya M. Zwahlen, Laura Shuttleworth, Ursula Wiedemann, Christina Spry, Kevin J. Saliba, Alexander G. Maier & Giel G. van Dooren. (2023) A screen of drug-like molecules identifies chemically diverse electron transport chain inhibitors in apicomplexan parasites. PLOS Pathogens 19:7, pages e1011517.
Crossref
Faizah S. Aljohani, Nadjet Rezki, Mohamed R. Aouad, Bassma H. Elwakil, Mohamed Hagar, Eman Sheta, Nermine Mogahed Fawzy Hussein Mogahed, Sanaa K. Bardaweel & Nancy Abd-elkader Hagras. (2022) Synthesis, Characterization and Nanoformulation of Novel Sulfonamide-1,2,3-triazole Molecular Conjugates as Potent Antiparasitic Agents. International Journal of Molecular Sciences 23:8, pages 4241.
Crossref
Joshua B. Radke, Bruno Melillo, Payal Mittal, Manmohan Sharma, Amit Sharma, Yong Fu, Taher Uddin, Arthur Gonse, Eamon Comer, Stuart L. Schreiber, Anil K. Gupta, Arnab K. Chatterjee & L. David Sibley. (2022) Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetase. Nature Communications 13:1.
Crossref
Nicholas C. Smith, Cibelly Goulart, Jenni A. Hayward, Andreas Kupz, Catherine M. Miller & Giel G. van Dooren. (2021) Control of human toxoplasmosis. International Journal for Parasitology 51:2-3, pages 95-121.
Crossref
Sharif Alhassan Abdullahi, Ngah Zasmy Unyah, Noshariza Nordin, Rusliza Basir, Wana Mohammed Nasir, Ashraf Ahmad Alapid, Yahaya Hassan, Tijjani Mustapha & Roslaini Abd Majid. (2020) Phytochemicals and Potential Therapeutic Targets on Toxoplasma gondii Parasite. Mini-Reviews in Medicinal Chemistry 20:9, pages 739-753.
Crossref
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis 179 196 .
Alex RosenbergMadeline R. LuthElizabeth A. Winzeler, Michael Behnke & L. David Sibley. (2019) Evolution of resistance in vitro reveals mechanisms of artemisinin activity in Toxoplasma gondii . Proceedings of the National Academy of Sciences 116:52, pages 26881-26891.
Crossref
Samuel D. Chorlton. (2019) Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis. Medical Hypotheses 133, pages 109376.
Crossref
Nancy Abd-elkader Hagras, Amal Farahat Allam, Hoda Fahmy Farag, Mervat Mostafa Osman, Thanaa Ibrahim Shalaby, Nermine Mogahed Fawzy Hussein Mogahed, Mona Mohamed Tolba & Amel Youssef Shehab. (2019) Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles. Experimental Parasitology 204, pages 107717.
Crossref
Neda Konstantinovic, Hélène Guegan, Tijana Stäjner, Sorya Belaz & Florence Robert-Gangneux. (2019) Treatment of toxoplasmosis: Current options and future perspectives. Food and Waterborne Parasitology 15, pages e00036.
Crossref
Qi-Wei Chen, Kai Dong, Han-Xiao Qin, Yi-Kai Yang, Jin-Lei He, Jiao Li, Zhi-Wan Zheng, Da-Li Chen & Jian-Ping Chen. (2019) Direct and Indirect Inhibition Effects of Resveratrol against Toxoplasma gondii Tachyzoites In Vitro . Antimicrobial Agents and Chemotherapy 63:3.
Crossref
Elisabet Gas-Pascual, Hiroshi Travis Ichikawa, Mohammed Osman Sheikh, Mariam Isabella Serji, Bowen Deng, Msano Mandalasi, Giulia Bandini, John Samuelson, Lance Wells & Christopher M. West. (2019) CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology. Journal of Biological Chemistry 294:4, pages 1104-1125.
Crossref
Mahbobeh Montazeri, Saeed Mehrzadi, Mehdi Sharif, Shahabeddin Sarvi, Shayesteh Shahdin & Ahmad Daryani. (2018) Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. Parasitology Research 117:10, pages 3045-3057.
Crossref
Jérémy Spalenka, Sandie Escotte-Binet, Ali Bakiri, Jane Hubert, Jean-Hugues Renault, Frédéric Velard, Simon Duchateau, Dominique Aubert, Antoine Huguenin & Isabelle Villena. (2018) Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box. Antimicrobial Agents and Chemotherapy 62:2.
Crossref
Carolina Fernández, Jesús Jaimes, María Camila Ortiz & Juan David Ramírez. (2016) Host and Toxoplasma gondii genetic and non-genetic factors influencing the development of ocular toxoplasmosis: A systematic review. Infection, Genetics and Evolution 44, pages 199-209.
Crossref
Ignacio M. Fenoy, Silvina S. Bogado, Susana M. Contreras, Vanesa Gottifredi & Sergio O. Angel. (2016) The Knowns Unknowns: Exploring the Homologous Recombination Repair Pathway in Toxoplasma gondii. Frontiers in Microbiology 7.
Crossref
Mohammed A. Afifi & Mohammed W. Al-Rabia. (2015) The immunomodulatory effects of rolipram abolish drug-resistant latent phase of Toxoplasma gondii infection in a murine model. Journal of Microscopy and Ultrastructure 3:2, pages 86-91.
Crossref
Sarmad N. Mageed, Fraser Cunningham, Alvin Wei Hung, Hernani Leonardo Silvestre, Shijun Wen, Tom L. Blundell, Chris Abell & Glenn A. McConkey. (2014) Pantothenic Acid Biosynthesis in the Parasite Toxoplasma gondii: a Target for Chemotherapy. Antimicrobial Agents and Chemotherapy 58:11, pages 6345-6353.
Crossref
CLEBER F. BARBOSA, ALEXANDRE A. TONIN, ALEKSANDRO S. DA SILVA, MARIA I. DE AZEVEDO, DANIELI U. MONTEIRO, EMILY P. WACZUK, THIAGO DUARTE, CARINE HERMES, GIOVANA CAMILLO, FERNANDA F. VOGEL, LUCIANA FACCIO, PAULA T. TONIN, PATRICIA WOLKMER, MARTA R. LEAL, MARTA M. M. F. DUARTE, RAFAEL N. MORESCO, SONIA T. A. LOPES & MARIO L. DE LA RUE. (2014) Diphenyl diselenide and sodium selenite associated with chemotherapy in experimental toxoplasmosis: influence on oxidant/antioxidant biomarkers and cytokine modulation. Parasitology 141:13, pages 1761-1768.
Crossref
Fabrice F. Boyom, Patrick V. T. Fokou, Lauve R. Y. Tchokouaha, Thomas Spangenberg, Alvine N. Mfopa, Ruffin M. T. Kouipou, Cedric J. Mbouna, Valerie F. Donkeng Donfack & Paul H. A. Zollo. (2014) Repurposing the Open Access Malaria Box To Discover Potent Inhibitors of Toxoplasma gondii and Entamoeba histolytica. Antimicrobial Agents and Chemotherapy 58:10, pages 5848-5854.
Crossref
Christelle Doliwa, Dong Xia, Sandie Escotte-Binet, Emma L. Newsham, Sanderson Sanya J.Dominique Aubert, Nadine Randle, Jonathan M. Wastling & Isabelle Villena. (2013) Identification of differentially expressed proteins in sulfadiazine resistant and sensitive strains of Toxoplasma gondii using difference-gel electrophoresis (DIGE). International Journal for Parasitology: Drugs and Drug Resistance 3, pages 35-44.
Crossref
Ira J. Blader, Gustavo Arrizabalaga & William J. SullivanJr.Jr.. 2013. Protein Phosphorylation in Parasites. Protein Phosphorylation in Parasites 199 216 .
C. Doliwa, S. Escotte-Binet, D. Aubert, F. Velard, A. Schmid, R. Geers & I. Villena. (2013) Induction of sulfadiazine resistance in vitro in Toxoplasma gondii. Experimental Parasitology 133:2, pages 131-136.
Crossref
Nicholas J Butler, João M Furtado, Kevin L Winthrop & Justine R Smith. (2012) Ocular toxoplasmosis II: clinical features, pathology and management. Clinical & Experimental Ophthalmology 41:1, pages 95-108.
Crossref
Danièle Maubon, Alexandre Bougdour, Yung-Sing Wong, Marie-Pierre Brenier-Pinchart, Aurélie Curt, Mohamed-Ali Hakimi & Hervé Pelloux. (2010) Activity of the Histone Deacetylase Inhibitor FR235222 on Toxoplasma gondii : Inhibition of Stage Conversion of the Parasite Cyst Form and Study of New Derivative Compounds . Antimicrobial Agents and Chemotherapy 54:11, pages 4843-4850.
Crossref
Michael PfallerTimothy Davis. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition 2073 2081 .
S Sudharshan, SudhaK Ganesh & Jyotirmay Biswas. (2010) Current approach in the diagnosis and management of posterior uveitis. Indian Journal of Ophthalmology 58:1, pages 29.
Crossref
Robert B. Nussenblatt. 2010. Uveitis. Uveitis 190 209 .
Peter L. Chiodini & Carmel M. Curtis. 2010. Antibiotic and Chemotherapy. Antibiotic and Chemotherapy 823 841 .
Kevin M. Brown & Ira J. Blader. (2009) The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis. Journal of Ocular Biology, Diseases, and Informatics 2:4, pages 214-222.
Crossref
Ildiko R. Dunay, Wing Chi Chan, Richard K. Haynes & L. David Sibley. (2009) Artemisone and Artemiside Control Acute and Reactivated Toxoplasmosis in a Murine Model. Antimicrobial Agents and Chemotherapy 53:10, pages 4450-4456.
Crossref
IRA J. BLADER & JEROEN P. SAEIJ. (2009) Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence . APMIS 117:5-6, pages 458-476.
Crossref
Orli Megged, Itamar Shalit, Isaac Yaniv, Jerry Stein, Salvador Fisher & Itzhak Levy. (2008) Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation. Pediatric Transplantation 12:8, pages 902-905.
Crossref
Pascale Meneceur, Marie-Anne Bouldouyre, Dominique Aubert, Isabelle Villena, Jean Menotti, Virginie Sauvage, Jean-François Garin & Francis Derouin. (2008) In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone . Antimicrobial Agents and Chemotherapy 52:4, pages 1269-1277.
Crossref
. (2006) Current World Literature. Current Opinion in Ophthalmology 17:6, pages 574-583.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.